People who inject drugs—risk environment
Policing drug users in Russia: risk, fear, and structural violence.
Sarang A, Rhodes T, Sheon N, Page K. Subst Use Misuse. 2010;45:813-64.
Policing drug users in Russia: risk, fear, and structural violence.
Sarang A, Rhodes T, Sheon N, Page K. Subst Use Misuse. 2010;45:813-64.
Optimal provision of needle and syringe programmes for injecting drug users: A systematic review.
Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA. Int J Drug Policy. 2010 Feb. [Epub ahead of print]
Flashblood: blood sharing among female injecting drug users in Tanzania.
McCurdy SA, Ross MW, Williams ML, Kilonzo GP, Leshabari MT. Addiction. 2010 Mar. [Epub ahead of print]
The Washington Needle Depot: fitting healthcare to injection drug users rather than injection drug users to healthcare: moving from a syringe exchange to syringe distribution model.
Small D, Glickman A, Rigter G, Walter T. Harm Reduct J. 2010 7:1.
Retention in Opioid Substitution Treatment: A Major Predictor of Long-Term Virological Success for HIV-Infected Injection Drug Users Receiving Antiretroviral Treatment.
Roux P, Carrieri MP, Cohen J, Ravaux I, Poizot-Martin I, Dellamonica P, Spire B. Clin Infect Dis. 2009; 49:1433-40.
A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia Region.
Sharma M, Oppenheimer E, Saidel T, Loo V, Garg R. AIDS. 2009;23:1405-13.
A Literature Review of International Implementation of Opioid Substitution Treatment in Prisons: Equivalence of Care? Larney S, Dolan K. Eur Addict Res. 2009; 15: 107-12.
Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction. 2009 Feb 10. [Epub ahead of print]
Altaf A, Saleem N, Abbas S, Muzaffar R. High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan. J Pak Med Assoc. 2009;59(3):136-40.
Todadze K, Lezhava G. Implementation of drug substitution therapy in Georgia. Cent Eur J Public Health. 2008;16(3):121-3.